ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.3835A>T (p.Met1279Leu)

gnomAD frequency: 0.00014  dbSNP: rs374497665
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000347920 SCV000237983 uncertain significance not specified 2016-10-14 criteria provided, single submitter clinical testing Missense variants in the TTN gene are considered 'unclassified' if they are not previously reported in the literature and do not have >1% frequency in the population to be considered a polymorphism. Research indicates that truncating mutations in the TTN gene are expected to account for approximately 25% of familial and 18% of sporadic idiopathic DCM; however, truncating variants in the TTN gene have been reported in approximately 3% of reported control alleles. There has been little investigation into non-truncating variants. (Herman D et al. Truncations of titin causing dilated cardiomyopathy. N Eng J Med 366:619-628, 2012) The variant is found in CARDIOMYOPATHY panel(s).
Invitae RCV001084704 SCV000286623 likely benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2024-01-22 criteria provided, single submitter clinical testing
Eurofins Ntd Llc (ga) RCV000725471 SCV000337163 uncertain significance not provided 2015-11-10 criteria provided, single submitter clinical testing
Institute of Human Genetics, University of Leipzig Medical Center RCV001262304 SCV001440118 uncertain significance Hypertrophic cardiomyopathy 9 2019-01-01 criteria provided, single submitter clinical testing This variant was identified as compound heterozygous.
Athena Diagnostics Inc RCV000725471 SCV001477133 likely benign not provided 2020-03-03 criteria provided, single submitter clinical testing
Ambry Genetics RCV002345661 SCV002621450 likely benign Cardiovascular phenotype 2020-03-09 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Revvity Omics, Revvity Omics RCV000725471 SCV003824774 uncertain significance not provided 2023-12-18 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.